Investor Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Credit Suisse Group AG (CS) Kessler Topaz Meltzer & Check LLP Radnor, Pennsylvania, UNITED STATES
RADNOR, Pa., April 28, 2021 (GLOBE NEWSWIRE) The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Southern District of New York against Credit Suisse Group AG (NYSE: CS) (“Credit Suisse”) on behalf of those who purchased or acquired Credit Suisse American Depositary Receipts (“ADRs”)
between October 29, 2020 and March 31, 2021, inclusive (the “Class Period”).
EBS EQUITY ALERT: Kessler Topaz Meltzer & Check, LLP Announces that a Securities Fraud Class Action Lawsuit was filed on Behalf of Investors of Emergent BioSolutions Inc. Kessler Topaz Meltzer & Check LLP Radnor, Pennsylvania, UNITED STATES
RADNOR, Pa. , April 28, 2021 (GLOBE NEWSWIRE) The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the District of Maryland against Emergent BioSolutions Inc. (NYSE: EBS) (“Emergent”) on behalf of those who purchased or acquired Emergent common stock
between July 6, 2020 and March 31, 2021, inclusive (the “Class Period”).
Deadline Reminder: Investors who purchased or acquired Emergent common stock